0001104659-19-019466.txt : 20190402
0001104659-19-019466.hdr.sgml : 20190402
20190402213920
ACCESSION NUMBER: 0001104659-19-019466
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190329
FILED AS OF DATE: 20190402
DATE AS OF CHANGE: 20190402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: IRONWOOD PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001446847
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38787
FILM NUMBER: 19727363
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-621-7722
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cyclerion Therapeutics, Inc.
CENTRAL INDEX KEY: 0001755237
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831895370
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-621-7722
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
a4.xml
4
X0306
4
2019-03-29
1
0001755237
Cyclerion Therapeutics, Inc.
CYCN
0001446847
IRONWOOD PHARMACEUTICALS INC
IRONWOOD PHARMACEUTICALS, INC.
301 BINNEY STREET
CAMBRIDGE
MA
02142
0
0
1
0
Common Stock
2019-03-29
4
A
0
15562455
0.00
A
15562555
D
Common Stock
2019-04-01
4
J
0
15562555
0.00
D
0
D
On March 29, 2019, Cyclerion Therapeutics, Inc. ("Cyclerion") issued a dividend of 155,624.55 shares of its common stock for each share of its common stock outstanding. As the sole holder of Cyclerion's common stock, Ironwood Pharmaceuticals, Inc. ("Ironwood") received 15,562,455 shares of common stock in the dividend.
Ironwood distributed all of the issued and outstanding shares of Cyclerion common stock to its stockholders on a pro rata basis as part of the separation of Cyclerion from Ironwood into two independent public companies.
IRONWOOD PHARMACEUTICALS, INC. By: /s/ Conor Kilroy, Vice President, General Counsel and Secretary
2019-04-02